Viveon Health Acquisition Corp. to Merge with Suneva Medical

Vesper Healthcare Acquisition Corp. Merges with The HydraFacial Company (BeautyHealth)

May 5, 2021

Healthcare Services

Vesper Healthcare Acquisition Corp. completed a business combination with The HydraFacial Company, taking the business public as The Beauty Health Company (ticker: SKIN) in a transaction that values HydraFacial at a pro forma enterprise value of $1.1 billion. The deal included a fully committed $350 million PIPE anchored by institutional investors (including Fidelity, Redmile, Principal, Camber and Woodline), and Linden Capital Partners and DW Healthcare Partners remain meaningful shareholders with management continuing in place.

Newborn Acquisition Corp Completes Business Combination with Nuvve; Nuvve Begins Trading on Nasdaq

March 22, 2021

Renewable Energy

Nuvve Holding Corp. completed a business combination with Newborn Acquisition Corp., enabling Nuvve to begin trading on the Nasdaq under the ticker NVVE. The transaction provided Nuvve approximately $62 million in cash proceeds (including a related private placement) to accelerate development and commercial deployment of its vehicle-to-grid (V2G) technology and related services.

Second Sight Medical Products Completes Merger with Nano Precision Medical and Becomes Vivani Medical, Inc.

August 30, 2022

Biotechnology

Second Sight Medical Products completed its merger with Nano Precision Medical and changed its name to Vivani Medical, Inc., with the combined company trading on Nasdaq under the ticker VANI. The transaction brings approximately $55 million in cash to advance Nano Precision Medical's NanoPortal implant portfolio (including lead asset NPM-119) into clinical development and places Nano Precision CEO Dr. Adam Mendelsohn as CEO of the combined company.

Chardan Healthcare Acquisition 2 Corp. Completes Business Combination with Renovacor, Inc.

September 2, 2021

Biotechnology

Renovacor, an early‑stage biotechnology company developing AAV‑based gene therapies for BAG3‑associated cardiovascular and CNS diseases, closed a business combination with special purpose acquisition company Chardan Healthcare Acquisition 2 Corp. (CHAQ) and will begin trading on the New York Stock Exchange as Renovacor, Inc., with approximately $95.1 million of gross proceeds (including a $30.0 million PIPE) to fund clinical development into 2023. The transaction preserves Renovacor’s existing management team and provides public-market access and capital to advance its lead program, REN‑001, toward IND submission and a Phase I/II trial.

SunMed Acquires Vyaire Medical's Respiratory & Anesthesia Consumables Business

March 28, 2023

Medical Devices

SunMed, a Frazier Healthcare Partners–backed medical-device manufacturer headquartered in Grand Rapids, Michigan, agreed to acquire Vyaire Medical’s respiratory and anesthesia consumables business, a unit that makes airway management and operative-care consumables. The deal—announced March 28, 2023 and completed May 1, 2023—expands SunMed’s product portfolio, manufacturing footprint and global reach; terms were not disclosed.

NanoVibronix, Inc. Acquires ENvue Medical Holdings Corp.

February 14, 2025

Medical Devices

NanoVibronix, Inc. (NASDAQ: NAOV) completed a stock-for-stock acquisition of ENvue Medical Holdings Corp., adding ENvue's FDA 510(k)-cleared electromagnetic navigation enteral feeding system to NanoVibronix's medical device portfolio. The transaction, which issued NanoVibronix common and Series X preferred shares to ENvue holders and was accompanied by a $500,000 senior convertible debenture private placement, is intended to expand commercial reach, product capabilities and operational efficiencies in enteral feeding and guided medical navigation.